Foundry Partners, LLC Harvard Bioscience Inc Transaction History

Foundry Partners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 23, 2019	SELL	$1.59 - $3.47 $1.15 Million - $2.5 Million	-720,540 Closed	0 $0
Q2 2019 Jul 18, 2019	BUY	$1.93 - $4.59 $379,003 - $901,361	196,375 Added 37.46%	720,540 $1.44 Million
Q1 2019 Apr 22, 2019	BUY	$2.77 - $4.38 $316,167 - $499,933	114,140 Added 27.84%	524,165 $2.26 Million
Q4 2018 Jan 10, 2019	BUY	$3.03 - $5.0 $360,766 - $595,325	119,065 Added 29.04%	529,090 $1.68 Million
Q4 2018 Jan 10, 2019	SELL	$3.03 - $5.0 $360,766 - $595,325	-119,065 Reduced 22.5%	410,025 $2.15 Million
Q3 2018 Oct 17, 2018	SELL	$5.0 - $6.65 $56,325 - $74,912	-11,265 Reduced 2.67%	410,025 $2.15 Million
Q2 2018 Jul 19, 2018	SELL	$4.2 - $5.95 $996,618 - $1.41 Million	-237,290 Reduced 36.03%	421,290 $2.25 Million
Q1 2018 May 16, 2018	SELL	$3.3 - $5.15 $240,124 - $374,739	-72,765 Reduced 9.95%	658,580 $3.29 Million
Q4 2017 Jan 25, 2018	SELL	$3.08 - $3.8 $72,303 - $89,205	-23,475 Reduced 3.11%	731,345 $2.41 Million
Q3 2017 Oct 31, 2017	BUY	$2.7 - $3.75 $2.04 Million - $2.83 Million	754,820	754,820 $2.83 Million

30.6M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Foundry Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Foundry Partners, LLC with notifications on news.